A randomized Phase II trial evaluating efficacy, safety, and tolerability of oral BI 409306 in attenuated psychosis syndrome: Design and rationale

AIM: Attenuated psychosis syndrome (APS), a condition for further study in the Diagnostic and Statistical Manual of Mental Disorders‐5, comprises psychotic symptoms that are qualitatively similar to those observed in schizophrenia but are less severe. Patients with APS are at high risk of converting...

Descripción completa

Detalles Bibliográficos
Autores principales: Keefe, Richard S. E., Woods, Scott W., Cannon, Tyrone D., Ruhrmann, Stephan, Mathalon, Daniel H., McGuire, Philip, Rosenbrock, Holger, Daniels, Kristen, Cotton, Daniel, Roy, Dooti, Pollentier, Stephane, Sand, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451588/
https://www.ncbi.nlm.nih.gov/pubmed/33354862
http://dx.doi.org/10.1111/eip.13083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451588/
https://www.ncbi.nlm.nih.gov/pubmed/33354862
http://dx.doi.org/10.1111/eip.13083

Ejemplares similares